NeurologyPeripheral Neuropathies

Mononeuropathy

Mononeuropathy is the damage or dysfunction of a single peripheral nerve, resulting in sensory, motor, or mixed deficits in the distribution of that nerve.

Mononeuropathy

Anatomy and Function: Key Peripheral Nerves

Understanding mononeuropathy requires knowing the anatomy — where nerves run, where they are vulnerable, and what they supply. Think of nerves as electrical cables running through tunnels: anywhere a tunnel is tight, the cable is at risk.

Upper Limb Nerves

Lower Limb Nerves

Aetiology (with Focus on Hong Kong)

Entrapment is the most common cause (MC) of mononeuropathy [1][2]. The aetiologies can be classified as follows:

Pathophysiology of Nerve Injury

Understanding how nerves get damaged is essential for predicting prognosis and guiding management.

Classification of Mononeuropathy

Clinical Features

The clinical features of mononeuropathy are determined by which nerve is affected and where along its course the lesion is. All features should be explicable by the anatomy.

Specific Mononeuropathies: Symptoms and Signs with Pathophysiological Basis

A. Upper Limb

B. Lower Limb

C. Cranial Nerve Mononeuropathies

Differential Diagnosis of Mononeuropathy

The differential diagnosis of mononeuropathy operates on two levels simultaneously. First, you must confirm that the clinical picture truly represents a single peripheral nerve lesion (anatomical differential — "Where is the lesion?"). Second, once localized, you must determine the cause (pathological differential — "What is the lesion?"). This two-tiered approach is fundamental to neurological reasoning and is heavily emphasized in the GC curriculum.


Level 1: Anatomical Differential — "Where Is the Lesion?"

Before you label something a mononeuropathy, you must exclude mimics at other anatomical levels that can produce similar motor/sensory deficits. A patient presenting with, say, wrist drop or foot drop could have a lesion anywhere from cortex to muscle.

Where is the lesion (anatomical differentials)? Cerebrum, corona radiata, internal capsule, brainstem, extrapyramidal system, spinal cord, anterior horn cells, nerve root, brachial plexus, peripheral nerve, neuromuscular junction, muscle, bone and joints, metabolic, functional [8]

The key anatomical mimics of mononeuropathy, organized by level:

Differential Diagnosis by Specific Presentation

Since different mononeuropathies present with different chief complaints, here are the key differentials organized by presentation:

References

[1] Senior notes: Maksim Medicine Notes.pdf (Section 11.12 Peripheral neuropathy, p.269) [3] Senior notes: Block A - Deterioration of eyesight in a diabetic patient_ diabetic complications.pdf (Diabetic Mononeuropathy section, p.7) [5] Senior notes: Maksim Surgery Notes.pdf (Section 5.2 Compression neuropathy, p.243–246) [6] Lecture slides: Neurology- Two cases of lower limb weakness.pdf (p.18–20) [8] Lecture slides: CFB_Neuro clinical skills demonstration_01.08.22_file to students.pdf (p.7–8) [9] Lecture slides: GC 056. Generalized muscle weakness.pdf (p.1) [10] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (Ptosis differential, p.1089) [11] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (Differential diagnosis of myopathies, p.706) [12] Senior notes: Maksim Surgery Notes.pdf (Approach to spine diseases, p.222; Peripheral vascular disease history, p.163) [13] Senior notes: Maksim Surgery Notes.pdf (Cauda equina syndrome, p.222)

Diagnostic Criteria, Diagnostic Algorithm, and Investigations for Mononeuropathy

Diagnostic Criteria by Specific Mononeuropathy

While there are no universal "diagnostic criteria" for mononeuropathy as a whole, certain specific entrapment neuropathies have well-established clinical diagnostic standards:

Investigation Modalities

1. Electrodiagnostic Studies (NCS + EMG) — The Cornerstone

These are the single most important investigations for confirming mononeuropathy, localizing the lesion, and characterizing the pathological process.

References

[1] Senior notes: Maksim Medicine Notes.pdf (Section 11.12 Peripheral neuropathy, p.269) [2] Senior notes: Ryan Ho Neurology.pdf (Section 10.2 Disease of the Peripheral Nerves, p.179) [3] Senior notes: Block A - Deterioration of eyesight in a diabetic patient_ diabetic complications.pdf (Diabetic Mononeuropathy section, p.7) [5] Senior notes: Maksim Surgery Notes.pdf (Section 5.2 Compression neuropathy, p.243–246) [8] Lecture slides: CFB_Neuro clinical skills demonstration_01.08.22_file to students.pdf (p.7–8) [14] Lecture slides: GCBA_Fundamentals_Neuro_Introduction to Neurological Investigations and Emergencies_Prof KC Teo.pdf (p.9) [15] Senior notes: MBBS Final MB (Medicine) (Felix PY Lai).pdf (EMG in inflammatory myopathy, p.1760) [16] Senior notes: Block A - Introduction to Haematological investigations (CBP, Clotting).pdf (SPE indications, p.27) [17] Senior notes: Adrian Lui Pediatrics Notes.pdf (Approach to generalized weakness investigation table, p.134)

Management of Mononeuropathy

Management by Aetiology

A. Entrapment Neuropathies (Most Common)

The classic stepwise approach applies: Conservative → Pharmacological → Surgical [5].

Special Considerations

References

[3] Senior notes: Block A - Deterioration of eyesight in a diabetic patient_ diabetic complications.pdf (Diabetic Mononeuropathy section, p.7) [5] Senior notes: Maksim Surgery Notes.pdf (Section 5.2 Compression neuropathy — CTS and cubital tunnel management, p.244–245) [18] Senior notes: Ryan Ho Endocrine.pdf (Diabetic neuropathy management, p.97)

Complications of Mononeuropathy

Complications of mononeuropathy arise from three main sources: (1) the direct consequences of nerve dysfunction (motor, sensory, autonomic deficits), (2) complications of the underlying aetiology, and (3) complications of treatment. Understanding each requires tracing the problem back to its pathophysiological origin — why does loss of a single nerve lead to these downstream consequences?


A. Complications from Motor Deficit

B. Complications from Sensory Deficit

D. Neuropathic Pain Syndromes

E. Complications of Treatment

References

[2] Senior notes: Ryan Ho Neurology.pdf (Section 10.2 Disease of the Peripheral Nerves — trophic changes, prognosis, p.179–180) [3] Senior notes: Block A - Deterioration of eyesight in a diabetic patient_ diabetic complications.pdf (Chronic diabetic complications, p.6–7) [5] Senior notes: Maksim Surgery Notes.pdf (CTS surgical complications, p.244–245) [18] Senior notes: Ryan Ho Endocrine.pdf (Diabetic neuropathy management, p.97) [19] Senior notes: Block A - Polyuria and polydipsia_ glucose metabolism; diabetes mellitus; diabetic ketoacidosis.pdf (Screening for chronic complications, p.20); Endocrine Interactive Tutorial.pdf (Non-healing diabetic foot ulcer case, p.5) [20] Senior notes: Handbook of Internal Medicine 2024.pdf (Painful neuromas management, p.393)

High Yield Summary

  1. Mononeuropathy = single nerve lesion. Most common cause is entrapment (MC) [1][2]. Most common overall is carpal tunnel syndrome [5].

  2. Localize the lesion by matching motor and sensory deficits to a single nerve's territory. Nerve territory ≠ dermatomal territory.

  3. LMN signs (weakness, wasting, fasciculation, hyporeflexia) are the hallmark of peripheral nerve lesions.

  4. Diabetic mononeuropathy: microangiopathy → mononeuritis multiplex. Classic presentations: CN III (pupil-sparing ptosis + divergent squint), CN VI (lateral rectus palsy), CN V (facial pain), CPN (foot drop) [3]. "Mix and match" presentations [3].

  5. Diabetic CN III vs compressive CN III: Pupil-sparing = ischaemic (diabetes). Pupil-blown = compressive (aneurysm) — the parasympathetic fibres run on the surface and are vulnerable to compression but not to central ischaemia.

  6. Double crush syndrome: proximal compression renders nerve more susceptible to distal entrapment [5].

  7. Key named signs: Tinel's (tap), Phalen's (wrist flexion), Froment's (paper grip), Wartenberg's (little finger abduction), wrist drop (radial), foot drop (CPN), claw hand (ulnar).

  8. Nerve conduction studies differentiate axonal (↓amplitude, normal velocity) from demyelinating (↓velocity, normal amplitude) pathology — only demyelinating neuropathies are usually susceptible to treatment [2].

  9. Seddon classification: Neurapraxia (myelin only, full recovery) → Axonotmesis (axon cut, connective tissue intact, good recovery) → Neurotmesis (complete transection, needs surgery).

  10. For prognosis and management: early recognition and decompression of entrapment neuropathies prevents progression from reversible demyelination to irreversible axonal degeneration.

High Yield Summary — Differential Diagnosis of Mononeuropathy

  1. Two-tiered approach: First localize (where?), then determine aetiology (what?).

  2. Anatomical mimics (from GC lecture slides): Cerebrum, brainstem, spinal cord, anterior horn cells, nerve root, plexus, peripheral nerve, NMJ, muscle, bone/joints, metabolic, functional [8].

  3. CPN palsy vs L5 radiculopathy: The classic differentiator is inversion (tibialis posterior) and hip abduction (gluteus medius) — both preserved in CPN palsy, both weak in L5 radiculopathy.

  4. CTS differential: Cervical spondylosis, pronator teres syndrome, thoracic outlet syndrome, peripheral neuropathy [5].

  5. Diabetic CN III vs PComA aneurysm: Pupil-sparing = ischaemic (DM). Pupil-blown = compressive (aneurysm).

  6. Ptosis differential: CN III palsy (down-and-out), Horner's (partial ptosis, miosis, NO eye deviation), MG (fatigable, no pupil changes), aponeurotic (age-related, most common acquired ptosis).

  7. Mononeuritis multiplex: Think DM (MC), vasculitis, sarcoid, Lyme, HIV, amyloid, HNPP, paraneoplastic.

  8. Double crush syndrome: proximal compression renders nerve susceptible to distal entrapment — always examine the whole pathway [5].

  9. Pathological differential framework: VINDICATE — Vascular, Infection, Neoplasm, Degenerative, Inflammatory, Congenital, Autoimmune, Trauma/Toxins, Endocrine [6][8].

High Yield Summary — Diagnosis and Investigations of Mononeuropathy

  1. Mononeuropathy is primarily a clinical diagnosis based on mapping deficits to a single nerve territory. Investigations confirm and characterize.

  2. NCS + EMG are the cornerstone investigations:

    • Axonal: ↓amplitude, normal velocity. Demyelinating: ↓velocity, normal amplitude [1].
    • Only demyelinating neuropathies are usually susceptible to treatment [2].
    • Normal NCS does not rule out CTS [5].
    • False –ve: 'Normal limits' NCV, early disease where structural changes are not obvious [14].
  3. Baseline bloods for aetiology: Glucose/HbA1c, TFT, B12, CBC, LRFT, ESR/CRP, autoimmune screen, SPE for unexplained neuropathy [16].

  4. MRI brain + MRA/CTA: mandatory for CN III palsy to exclude PComA aneurysm (compressive = pupil-blown, ischaemic/DM = pupil-spared).

  5. Nerve biopsy: last resort for inflammatory / infective / infiltrative disorders [1] — usually sural nerve.

  6. Ultrasound of nerve: increasingly used for entrapment neuropathies — shows nerve swelling at compression site, can visualize ganglions and other structural causes.

  7. Always ask: Why did this nerve get entrapped? Screen for predisposing conditions (DM, hypothyroid, RA, pregnancy, acromegaly, renal failure).

High Yield Summary — Management of Mononeuropathy

  1. Stepwise approach for entrapment: Conservative (splint, physiotherapy, lifestyle) → Pharmacological (local steroid injection, pyridoxine) → Surgical (decompression) [5].

  2. CTS surgical indications: Unresponsive to conservative Rx for 6 weeks, associated sensory/motor deficit, axonal loss on NCS [5].

  3. CTS surgery: Carpal tunnel release = division of flexor retinaculum, open vs endoscopic. Complications: persistent symptoms (inadequate release), nerve injury (palmar cutaneous branch), vascular injury (superficial palmar arch) [5].

  4. Cubital tunnel surgery: Decompression in-situ, medial epicondylectomy, or anterior transposition of ulnar nerve [5].

  5. Diabetic mononeuropathy: Generally self-limiting; management = glycaemic control + neuropathic pain relief (gabapentin/pregabalin/amitriptyline) + supportive measures [18]. MRI brain to exclude stroke/aneurysm if cranial nerve involved.

  6. Traumatic nerve injury: Neurapraxia → observe. Axonotmesis → serial monitoring (recovery ~1 mm/day). Neurotmesis → urgent surgical repair.

  7. Vasculitic mononeuritis multiplex: Emergency immunosuppression (high-dose steroids ± cyclophosphamide/rituximab) to prevent further nerve infarction.

  8. Bell's palsy: Prednisolone within 72 hours + eye care. ~70% complete recovery.

  9. Neuropathic pain: First-line = gabapentin/pregabalin or amitriptyline. Gabapentinoids work by binding α2δ Ca²⁺ channel subunit → ↓excitatory neurotransmitter release at hyperexcitable nerve terminals.

  10. Always treat the underlying condition: DM → glycaemic control; hypothyroidism → levothyroxine; RA → DMARDs; obesity → weight loss.

High Yield Summary — Complications of Mononeuropathy

  1. Irreversible weakness occurs when axonal degeneration is prolonged ( > 12–18 months) → motor endplates degenerate → muscle replaced by fat/fibrosis. Recovery occurs unless axonal loss has occurred [2]. This is why early treatment matters.

  2. Neuropathic ulcers: Loss of protective sensation + microangiopathy + autonomic dysfunction → non-healing ulcers [19], especially on the feet in diabetics. Can lead to osteomyelitis and amputation.

  3. Charcot joint: Loss of proprioception/pain → repeated joint microtrauma → progressive destruction. Trophic changes are a recognized complication of peripheral neuropathy [2].

  4. Contractures: Develop within weeks if paralysed joints are not splinted and mobilized. Prevention (splinting + ROM exercises) is far easier than treatment of an established contracture.

  5. CRPS: Disproportionate pain + autonomic + trophic changes after nerve injury. Early physiotherapy is the best preventive measure.

  6. Surgical complications of carpal tunnel release: persistent symptoms (inadequate release), nerve injury (palmar cutaneous branch), vascular injury (superficial palmar arch) [5].

  7. Diabetic mononeuropathy is a marker of systemic microvascular disease → always screen for the Big 3: retinopathy, nephropathy, neuropathy [19]. Good glycaemic control delays all complications [3].

  8. Neuropathic pain: Affects quality of life profoundly. First-line pharmacotherapy: gabapentin/pregabalin or amitriptyline.

On this page

No Headings